Funder
Japan Agency for Medical Research and Development
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference12 articles.
1. World Health Organization. Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant TB. 2018. Available from: https://www.who.int/tb/publications/2018/WHO_technical_report_concentrations_TB_drug_susceptibility/en/. Accessed November 24, 2020.
2. Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function;Flanagan;Antimicrob Agents Chemother,2015
3. Treatment of highly drug-resistant pulmonary tuberculosis;Conradie;N Engl J Med,2020
4. Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan–Results of a randomised, multicentre phase 3 study;Mikamo;J Infect Chemother,2018
5. Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid;Flanagan;Pharmacotherapy,2014
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献